Longeveron Inc. Common Stock

LGVNNASDAQ • USD
ThemeLongevity & Aging›Age-Related Therapeutics
2.49 USD
↘ 0.48 (16.16%)AT CLOSE (03:59 PM EST)
2.45
↘ 0.04 (1.61%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
2.45
↘ 0.04 (1.61%)
🔴Market: CLOSED

LGVN is currently priced at $2.49. The technical outlook is "Neutral" and the fundamental picture shows "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, LGVN appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 13, 2026.

Open?$2.90
High?$2.90
Low?$2.40
Prev. Close?$2.97
Volume?60.4K
Avg. Volume?94.9K
VWAP?$2.54
Rel. Volume?0.64x
Bid / Ask
Bid?$2.25 × 600
Ask?$2.40 × 7.0K
Spread?$0.15
Midpoint?$2.33
Valuation & Ratios
Market Cap?7.9M
Shares Out?3.0M
Float?2.6M
Float %?85.7%
P/E Ratio?N/A
P/B Ratio?0.76
EPS?-$7.36
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.
Themes
Longevity & Aging›Age-Related TherapeuticsHealthcare - Genomics & Precision Medicine›Gene Therapy & Gene Editing
Employees
38
Market Cap
9.5M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.longeveron.com
Listed
2021-02-12
Address
1951 NW 7TH AVENUE
MIAMI, FL 33136
Phone: 305-302-7158
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
35
Short Sent.?
45
Piotroski F-Score?2/9Weak
Altman Z-Score?-16.48Distress
Confidence?59%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?6.03%Elevated
Short Interest?157.1K
Days to Cover?2.2
Free Float2.6M
Avg Daily Volume72.1K
Settlement Date2026-10-30
Financial Health
Current Ratio?2.23Strong
Quick Ratio?2.23Strong
Cash Ratio?1.98Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
92/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.76CHEAP▾
P/S?
Peers
100
S&P
18
6.69FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.1CHEAP▾
EV/Sales?
S&P
97
-1.80CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-225.7%WEAK▾
ROA?
S&P
3
-151.6%WEAK▾
Cash Flow & Enterprise
FCF?$-20534000
Enterprise Value?$-2138387
Fundamentals ratios updated end of day
MarketsMoversWatchlist